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Abstract
Coenzyme Q10 is a powerful antioxidant used on cardiovascular, neurodegenerative and cancer diseases. Its hydrophobic
nature do limit its applications, because human body absorbs it with difficulty, that is why it was proposed to increase its
bioavailability by diminishing the particle size using supercritical carbon dioxide. It was determined experimentally the
phase behavior of the coenzyme in a supercritical system. The equilibrium data and a factorial 2k experimental design were
utilized to find how the sha e a d size of the microparticles are affected by temperature, coQ10 concentration and nozzle
diameter. Microparticles were characterized using infrared spectrometry and chromatography. For verify the fundamental
chemical structure, the size and the shape of the microparticles was used scanning electronic microscopy. It was found
a significant decrease in particle size and a modification of physical structure. The antioxidant power of coQ10 after
micronization was measured, showing an increase of this property. Finally, in order to evaluate the bioavailability, the
kinetic of solubility was determined in ethanol, having a substantial increase on solubilization speed of micronized coQ10
compared with the commercial one.
Keywords: coenzyme Q10, bioavailability, micronization, supercritical carbon dioxide.
Resumen
La coenzima Q10 es un potente antioxidante utilizado en las enfermedades cardiovasculares, neurodegenerativas y el
ca´ncer. Su naturaleza hidrofo´bica limita sus aplicaciones, ya que el cuerpo humano la absorbe con dificultad, es por
eso que se propone aumentar su biodisponibilidad al disminuir el taman˜o de partı´cula utilizando dio´xido de carbono
supercrı´tico. Se determino´ experimentalmente el comportamiento de fases de la coenzima en un sistema supercrı´tico.
Los datos de equilibrio y un disen˜o experimental factorial 2k se utilizaron para encontrar co´mo la forma y el taman˜o
de las micropartı´culas se ven afectados por la temperatura, la concentracio´n de coQ10 y dia´metro de la boquilla. Las
micropartı´culas se caracterizaron mediante espectrometrı´a de infrarrojo y cromatografı´a. Para verificar la estructura
quı´mica fundamental, el taman˜o y la forma de las micropartı´culas se utilizo´ microscopı´a electro´nica de barrido. Se encontro´
una disminucio´n significativa en el taman˜o de partı´cula y una modificacio´n de la estructura fı´sica. El poder antioxidante
de coQ10 micronizada se incremento´ de manera importante. Por u´ltimo, con el fin de evaluar la biodisponibilidad, se
determino´ la cine´tica de la solubilidad en etanol, y se encontro´ un aumento sustancial en la velocidad de solubilizacio´n de
la coQ10 micronizada en comparacio´n con la coenzima Q10 comercial.
Palabras clave: coenzima Q10, biodisponibilidad, micronizacio´n, dio´xido de carbono supercrı´tico.
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1 Introduction
CoQ10 is an orange colored substance present in every
cell in the human body accomplishing an essential roll
on adenosine triphosphate (ATP), which is the source
of energy used by cells to carry on several chemical
reactions needed to sustain (Pecar and Dolecek, 2007).
Utilization of coQ10 on medical treatments was
made in Japan for the first time, in order to attack
cardiovascular diseases and other heart conditions.
Sometime later it was implemented in medical
treatments against cancer, reporting several benefits
to health (Pecar and Dolecek, 2007; Laplante et
al., 2009). The therapeutically value of coQ10 has
been also proved with success along with standard
medical therapy on diabetes, pediatric cardiopathies
and neurodegenerative diseases like Parkinson and
Huntington (Pecar and Dolecek, 2007; Bhagavan and
Chopra, 2007; Galpern and Cudkowic, 2007).
However the hydrophobic nature of this compound
makes difficult its absorption in the human organism.
Several commercial formulations have been proposed
with coQ10, but the challenge of increasing its
capability to be dispersed in aqueous solutions has
not been solved and hence its bioavailability. This
work has the aim to increase coQ10 bioavailability
by raising its solubility in aqueous media, through
the increase of superficial contact area with solvents
decreasing the particle size of microcapsules obtained
by micronization. An application of supercritical
fluids is in fact the production of micronized particles
by using several techniques: Rapid Expansion
Supercritical Solutions (RESS), which has been used
successfully to process high valued compounds, being
able to control particle sizes and size distribution
by handling variables involved on RESS (Santos and
Meireles, 2013). Finally and due to the low solubility
of the coenzyme in CO2SC, it has been proposed the
use of acetone as a cosolvent.
2 Materials and methods
2.1 Materials
CoQ10 was provided by Nano Nutrition S. de R.L.
de C.V. (Mexico), carbon dioxide (CO2) high purity
(99.99%) was acquired from Infra S.A. de C. V.
(Mexico), acetone (99.8%) was obtained from J.T.
Baker degree HPLC (Mexico).
2.2 RESS technique and equipment
The RESS process consists of two phases, a phase
of solubilization of the solute in a supercritical fluid
(FSC) (in case of a solute with low solubility on
FSC, it is possible to use a co-solvent) and then a
fast expansion or depressurization. Those phases are
illustrated on figure 1.
The equipment used to produce microparticles by
RESS technique is shown on figure 2. It consists
of two systems, a system with high pressure and a
system to feed and pressurize CO2. The high pressure
system is composed by a CO2 compression cylinder
(pressure generator High Pressure Equipment, HIP)
and a high pressure cell (HPC), where the supercritical
solution is prepared and maintained on equilibrium
until the expansion that produces microparticles; this
system is provided with a pressure (SENSOTEC,
model TJF/7039-03), indicator device (SENSOTEC
model GM), a temperature regulator (Cole-Palmer,
model Polystat®) and a thermometer (FLUKE, model
1504).
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Figure 14. HPLC-r of micronized coQ10 by RESS 552 
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Figure 15. Kinetic solubility of coQ10 in ethanol. 554 
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Figure 1. Steps of RESS 561 
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564 Figure 1. Steps of RESS.
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Figure 2. High pressure equipment 566 
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569 Figure 2. High pressure equipment.
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Table 1. Experimental design.
Treatment CO2 in supercritical
solution (%weight)
Temperature (°C) coQ10 in supercritical
solution (%weight)
Nozzle diameter (µm)
1 80 35 0.20 50
2 80 35 0.20 100
3 80 45 0.20 50
4 80 45 0.20 100
5 80 55 0.20 50
6 80 55 0.20 100
7 50 35 0.50 50
8 50 35 0.50 100
9 50 55 0.50 50
10 50 55 0.50 100
11 80 35 1 50
12 80 35 1 100
13 80 55 1 50
14 80 55 1 100
15 50 35 2.5 50
16 50 35 2.5 100
17 50 45 2.5 50
18 50 45 2.5 100
19 50 55 2.5 50
20 50 55 2.5 100
2.3 Formation of microparticles using
RESS technique
The high pressure cell was loaded with an
approximately 5 g of the coQ10-acetone solution,
depending on conditions to be studied and established
by an experimental design type 2k, with k=4 (table
1, three levels of temperature were used to observe
their effect). A mass between 10 and 20 g of CO2 was
added, previously calculated with density determined
at P and T from inside the addition tank), in order to
keep the desired CO2 percentage (50 and 80%). The
system is fixed on process conditions (P = 200 bar
and temperature determined by experimental design),
letting the system to reach a stable homogeneous
phase during 30 minutes. The nozzle is then inserted
in the aluminum box, followed by the expansion
of the supercritical solution through a nozzle with
a predetermined diameter (50 or 100 µm), being
necessary to maintain a constant pressure during the
process.
2.4 Scanning Electron Microscopy (SEM)
The micrographies of commercial and micronized
coQ10 were obtained with a scanning electron
microscopy low vacuum JEOL JSM-5900 LV. The
measurement of the particles diameter has been
made with the software Digital Micrograph® (Version
1.71.38. Gatan, Inc.). A minimum of 100
microparticles per treatment were observed.
2.5 Infrared Spectrophotometry (IR)
The Infrared spectra of commercial or micronized
coQ10 were determined with a Perkin Elmer
Spectrophotometer, model 1600, using a resolution of
4 cm−1 and 3 times scan. Potassium bromide has been
used to place the samples.
2.6 Liquid Chromatography with reverse
phase (HPLC-r)
Chromatograms of commercial or small size
micronized coQ10 were obtained by Liquid
chromatography with a Hewlett Packard, series
II1090, equipped with a flame ionization detector. A
column Purospher 125 × 1 RP18 of 5 µm (C18). The
fluid phase was a solution of methanol:n-hexane (9:1)
flowing at 1.5 ml min−1.
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2.7 Antioxidant capability (Method
reducing the radical DPPH)
Determination of antioxidant capability of micronized
coQ10 was carried out with the radical DPPH
(1,1-diphenyl-2-picryl-hidrazyl) discoloring method
(Garcı´a-Ma´rquez et al., 2012; Cotelle et al., 1996;
Ga´mez et al., 1998; Cavin et al., 1998), this method
is based on the capability of antioxidant compounds
to catch electrons from the free radical DPPH. First,
it was prepared a blend with 50 µL of a coenzyme
solution and 150 µL of an ethanolic solution of DPPH
(concentration of 1000 µM coQ10 / DPPH and 100 µM
DPPH/ethanol). The blend was incubated during 30
minutes at 37°C constantly stirred. The absorbance
was measured at 515 nm on an Ultra Microplate
Reader, model ELX 808, Bio Tek Instruments Co.
Percentage of antioxidant activity against radical
DPPH was calculated with the following equation:
%inhibition =
Absorbancecontrol − Absorbanceproblem
Absorbancecontrol
×100
(1)
2.8 Kinetics of solubility in ethanol
Solubility curves of commercial or smaller
micronized coQ10 were measured by UV - VIS
spectrophotometry. Model Cary 50 CONC, Varian.
Absorbance at 407 nm was correlated to concentration
of coQ10 in ethanol, by preparing solutions from
0.00 to 0.16% (w/w) of coQ10 (0 to 1270 mg/L).
To determine solubility kinetics, absorbance was
measured as a function of time, initiating with a
saturated solution (7 mg of coQ10 and 5 ml of
ethanol). A measurement was made every 1 hour
until accomplishment of 10 points.
3 Results and discussion
Obtained results emerging from the experimental
design are showed on table 2, besides characterization
results of commercial coQ10 particles.
Table 2. Summary results of microparticles
Process variables Response variables
coQ10 concentration in
supercritical solution
(%weight)
Temperature
(°C)
Nozzle
diameter
(µm)
Average
diameter
(µm)
Standard
deviation
(µm)
Maximum
(µm)
Minimum
(µm)
coQ10 commercial 79.78 48.13 334.00 18.00
0.2 35 50 3.60 1.16 9.94 1.32
100 3.70 0.96 6.37 1.85
45 50 3.30 1.05 9.02 1.25
100 3.45 1.01 7.70 1.56
55 50 2.81 1.01 7.55 1.02
100 3.33 1.03 8.41 1.49
0.5 35 50 3.52 1.00 7.35 1.83
100 3.20 0.88 5.85 1.00
55 50 3.84 1.02 6.91 1.26
100 3.73 1.05 7.65 1.59
1.0 35 50 5.91 3.48 17.90 1.62
100 3.49 1.52 9.77 0.99
55 50 21.51 3.67 29.76 13.67
100 21.57 3.80 29.96 14.80
2.5 35 50 5.00 3.09 14.98 1.79
100 11.76 3.81 24.17 5.15
45 50 16.42 3.60 25.32 6.60
100 12.11 3.63 26.20 5.60
55 50 21.71 4.48 34.89 9.26
100 13.73 3.53 27.43 6.01
52 www.rmiq.org
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Figure 3. SEM images of coQ10. (A and B commercial coQ10, C and D micronized 2,5% 576 
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Figure 3. SEM images of coQ10. (A and B
commercial coQ10, C and D micronized 2,5% wt
coQ10).
A decrease of particle size of commercial coQ10
particles was observed, which originally had an
average diameter of 79.78 µm. In this case particles
with average diameter 0.84 to 21.71 µm were obtained.
Besides, micronized particles had size distributions
narrower than the commercial ones, which mean that
their differential between maximal and minimal values
(DMM) was around 11.5 µm and 316 µm respectively.
There existed also modifications of coQ10
morphology, as showed on figure 3. Clusters or
accumulations of encapsulating material on the
surface of commercial coenzyme were essentially
amorphous (figure 3A), whereas those on micronized
particles were generally spherical (figure 3C). It was
observed that micronization reorganized structures
(figures 3B and 3D), by doing smaller, thinner and
cordoned flakes, allowing to imagine the growing
dynamic of microparticles, having at the same time
an increase of superficial area of the coenzyme.
3.1 Effect of process variables on
microparticles shape, size and size
distribution
3.1.1 Effect of temperature
The figures 4 and 5 show the effect of the temperature
for concentrations of 0.2% and 2.5% to nozzle
diameters of 50 µm (figure 4) and 100 µm (figure 5)
where it is observed that to a concentration of CoQ10
to 0.2% doesn’t show up an effect of the temperature
with distributions in the closed particle size, contrary
to concentration of 2.5% where the particle size is
22 
 
 617 
 618 
Figure 4. Temperature effect in coQ10 particle size (nozzle diameter: 50 µm) 619 
 620 
 621 
 622 
 623 
 624 
 625 
 626 
 627 
 628 
 629 
630 
Figure 4. Temperature effect in coQ10 particle size
(nozzle diameter: 50 µm).
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Figure 5. Temperature effect in coQ10 particle size (nozzle diameter: 100 µm) 632 
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646 
Figure 5. Temperature effect in coQ10 particle size
(nozzle diameter: 100 µm)
increased with the increment of the temperature with
more deviations standard. For all the following
figures, the dotted shown lines are tendencies.
At a concentration of 0.2% (w/w) of coQ10 in
the supercritical solution, it was not observed a
significant effect of temperature on microparticles size
or morphology; particles diameter was around the
value of 3.4 µm, with standard deviations between
0.96-1.16. The same effect was observed for a
concentration of 0.5% of coQ10 (3.57 µm average
size, with standard deviations between 0.88-1.05).
However, for concentrations of 1.0% and 2.5%, an
increase on temperature induced a race on particle
diameter with more deviations standard; taking into
account both nozzle diameters. At 2.5% of coQ10 and
nozzle diameter of 50 µm, an increase on temperature
induced bigger particle sizes, with a nozzle of 100 µm,
a less significant increase of diameter was the result.
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Figure 6. coQ10 microparticles with 0.2 wt% coQ10 : A) and B) 35°C; C) and D) 55°C 648 
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Figure 6. coQ10 microparticles with 0.2 wt% coQ10 :
A) and B) 35°C; C) and D) 55°C.
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Figure 7. coQ10 microparticles with 1 wt% coQ10 : A) and B) 35°C; C) and D) 55°C 664 
 665 
666 
667 
Figure 7. coQ10 microparticles with 1 wt% coQ10 : A)
and B) 35°C; C) and D) 55°C.
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Figure 8  coQ10 microparticles with 2.5 %wt coQ10: A) and B) 35°C; C) and D) 55°C 674 
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Figure 8. coQ10 microparticles with 2.5 %wt coQ10:
A) and B) 35°C; C) and D) 55°C.
Particle sizes average from 5 µm to 21.71 µm with
deviations standard up of 3 µm.
The morphology of coQ10 to concentration of
0.2% is solid particles of uniform size shown in
the figures 6A-D at 35º and 55ºC. In the case of
coQ10 concentration of 1.0% it was found that an
increment in the temperature induces an increase in
the particle diameter; to both temperatures they are
formed spherical accumulations of flakes (figures 7A
and C), however at 35°C solid microparticles and
flakes (figure 7B) are observed also, while at 55°C,
circular accumulations of flakes (figure 7D).
For a concentration of 2.5%, the forms of the
particles are accumulations of flakes of sizes to 5 µm.
In the figures 8A and B morphologies are shown to
35°C and 8C and D at 55°C.
Summarizing, at low concentrations of coQ10 in a
supercritical solution (0.2 and 0.5% w/w), temperature
had not an effect on particle size neither on their
morphology, but at higher concentrations (1.0 and
2.5% w/w), an increase of temperature carried an
increase on microparticles size, and a modification on
their morphology, as well as an effect on particle size
distribution (Kwauk and Debenedetti, 1993; Carrillo-
Navas et al., 2011), developing a mathematical
model for the RESS technique, founded that an
increase of temperature produced more important
54 www.rmiq.org
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particle diameters. The same effect was observed by
micronizing salicylic acid (Reverchon et al., 1993;
Yildiz et al., 2007), naphthalene (Liu and Nagahama,
1996; Tu¨rk, 1999), hyaluronic acid (HYAFF-11)
(Benedetti et al., 1996), benzoic acid (Tu¨rk, 2000;
Helfgen et al., 2001; Tu¨rk et al., 2002), perfluoro
polyether diamide (PFD) (Chernyak et al., 2001),
tetraphenyl porphyrine fluorated (TBTPP) (Sane and
Thies, 2005) and chitin (Salinas-Herna´ndez et al.,
2009). On the other hand, it has been determined
that temperature has no effect on size or morphology
of cholesterol (Tu¨rk, 1999; Helfgen et al., 2001),
griseofulvin (Helfgen et al., 2001; Tu¨rk et al., 2002),
β-sitosterol (Tu¨rk et al., 2002), aspirine (Huang and
Moriyoshi, 2006) or felodipine (FLD) (Chiou et al.,
2006) microparticles. This could be related to a
low solubility of those compounds in supercritical
solvents, which produces no detectable changes on
microparticles shape and size.
3.1.2 Effect of nozzle diameter
At concentrations of coQ10 in a supercritical solution
of 0.2, 0.5 and 1.0% w/w, the nozzle diameter had
no significant effect on shape, size or size distribution
of microparticles, however at 2.5% w/w and 35°C, an
increase of the nozzle diameter induced an increase
of the particle diameter, whereas 45ºC and 55°C the
opposite effect was observed (figure 9). Morphology
and size distribution were not affected by the nozzle
diameter, being the average DMM of 5.53 µm with a
nozzle of 50 µm, and of 5.58 µm with a nozzle of 100
µm.
Foster and coworkers (Foster et al., 2003),
reported no effect of the nozzle diameter on shape
or particle size of micronized ibuprofen manufactured
with the RESS technique, perhaps this is due to
its low solubility. The team work of Huang, also
observed the phenomenon during production of aspirin
microparticles (Huang et al., 2005). On the other
hand, progesterone was micronized and the results
founded were that bigger nozzle diameters produced
more important particle sizes (Alessi et al., 1996),
being the same phenomenon observed for micronized
loperamide (Huang and Moriyoshi, 2006).
3.1.3 Effect of coQ10 concentration in the supercritical
solution
At 35°C an increase of the coQ10 concentration in
the supercritical solution produced a small increase of
microparticles diameter.
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Figure 9. Effect of nozzle diameter on the size of coQ10 microparticles  (2.5 %wt coQ10) 683 
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Figure 9. Effect of nozzle diameter on the size of
coQ10 microparticles (2.5 %wt coQ10).
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Figure 10. Effect of coQ10 concentration on the size of microparticles at 35 ºC 689 
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694 Figure 10. Effect of coQ10 concentration on the size
of microparticles at 35 ºC.
This effect is shown on figure 10, with a 100 µm
diameter nozzle. The augmentation is more significant
in a range of concentrations between 1.0 to 2.5%
w/w of coQ10. The distribution of the particle
size is also affected, to smaller concentrations they
show up closed values that it is increased to high
concentrations.
At 55°C the concentration of coQ10 effect in the
particle size was especially more significant when
concentration went from 0.5 to 1.0% (figure 11).
In a concentrations range from 1.0 to 2.5%, and
using a 50 µm nozzle the concentration effect is no
longer observed. Distributions of particle size are also
observed closed to smaller concentrations contrary to
high concentrations.
In general, it was observed in this work how an
increase of the coQ10 concentration in a supercritical
solution induces an increase of the particle size
www.rmiq.org 55
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Figure 11. Effect of coQ10 concentration on the size of microparticles at 55 ºC 697 
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701 Figure 11. Effect of coQ10 concentration on the size
of microparticles at 55 ºC.
and of the width of the size distribution or DMM,
besides a modification of microparticles morphology
at 55°C. This same effect has been found by Tom and
Debenedetti (Tom and Debenedetti, 1994) when they
produced polymeric microparticles, by Lele and Shine
(Lele and Shine, 1994) with PMMA. At unsaturated
conditions of the supercritical (0.08% w/w) dusts were
formed, whereas at conditions closer to saturation
(0.263% w/w) bigger fibers were produced.
Santoyo-Arreola (Santoyo-Arreola, 2006),
determined that at concentrations around 20% of 1,1-
Dihydroperfluorooctyl Methacrylate (PFOMA) bigger
microspheres were obtained (5 µm) than at 5% (2
µm). Salinas-Herna´ndez et al. (2009) found that using
chitin, an increase of its concentration is followed by
an increase of the average particle diameter, of the
standard deviation and of the width of particle size
distribution DMM.
The augmentation of the average particle diameter
motivated by an increase of the concentration
could be due to a higher quantity of solute in
the supercritical solution, facilitating contacts and
interactions between particles of coQ10, inducing
bigger circular accumulations. According to Tu¨rk
(2009), the speed of particles collision is directly
proportional to the solute concentration to the power
of two.
3.2 Spectrophotometry IR
IR spectra of commercial or micronized coQ10 are
shown in figure 12. In this work, conditions
such as pressure, temperature and contact with
organic solvents (supercritical carbon dioxide and
acetone) suffered by the coenzyme during RESS
33 
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Figure 12. IR spectrum of commercial and micronized coQ10 by RESS 704 
 705 
 706 
 707 
708 Figure 12. IR spectrum of commercial and micronized
coQ10 by RESS.
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Figure 13. HPLC-r of commercial coQ10 710 
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Figure 13. HPLC-r of commercial coQ10.
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Figure 14. HPLC-r of micronized coQ10 by RESS 715 
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Figure 14. HPLC-r of micronized coQ10 by RESS.
technique, they did not induced any modification of
wavelength of vibration of the electron bonds in the
coQ10 molecule that could insinuate interactions of
functional groups. We can also note that there was
no remaining molecule of acetone, because if there
were, this solvent would absorb IR light at 1240 cm−1,
wavelength characteristic of the keto group.
3.3 Liquid chromatography with reverse
phase (HPLC-r)
Chromatograms of commercial or micronized coQ10
are represented on figures 13 and 14 respectively.
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Table 3. t test: Statistical analysis
Group N Average, % Standard
deviation
commercial coQ10 4 2.14 1.35
micronized coQ10 6 8.00 2.11
Retention times of both samples are similar (9.787 and
9.871 minutes), putting in evidence that micronized
molecules of coQ10 have not been modified in their
fundamental chemical structure by the conditions of
the process during the RESS technique.
3.4 Antioxidant capability
The antioxidant capability of commercial coQ10 and
microparticles of coQ10 elaborated with a treatment
allowing to obtain the smallest particle diameter
(concentration of 0.5% in a supercritical solution at
55°C and 200 bar of pressure, with a nozzle diameter
of 50 µm) was determined using the method of radical
reduction of DPPH. A statistical analysis of results
(test t) was made using the software Minitab® 15
(Statistical software. Minitab, Inc.). Obtained results
are shown in table 3.
Normality and variance equality test were carried
out, having a P=0.443 and 0.581, respectively. The
difference between the average value of both groups
was 5.86%, reporting a t value of 4.875 with 8
degrees of freedom (P=0.001) and with a confidence
interval of 95% of the interval between average values
from 3.087 to 8.629. The alpha value used for the
test was 0.050. With this statistical analysis it was
proved that the difference between average values
for micronized coQ10 and commercial coQ10 is more
important the one expected randomly and, hence
there is a significant difference between antioxidant
capabilities of both groups.
As shown in table 3, the average of the antioxidant
capability of commercial coQ10 is 2.14%, whereas
for micronized coQ10 is 8.00%, showing this way a
significant increase of the antioxidant capability of the
coenzyme micronized.
This phenomenon is possibly due to a reduction of
the particle size that induces an increase of the contact
surface between the coenzyme and free radicals
present in the surrounding medium, making possible
to accomplish the oxidant trapping function of the
coQ10.
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Figure 15. Kinetic solubility of coQ10 in ethanol.
3.5 Kinetics of solubility in ethanol
The kinetic of solubility of coQ10 in ethanol at
25°C is reported on figure 15, reaching a maximal
concentration for both coenzymes after 10 hours
and being of 1200 mg/L. Since the first hour the
micronized coenzyme showed a solubility of 53%
(640 mg/L) and it continues to increase toward the
hour 7 where solubility reaches saturation, whereas
coQ10 reaches this concentration 6 hours later, getting
saturation after 10 hours. The concentration of
micronized coenzyme, compared with the commercial
one is higher after 10 hours, being 4 times superior
at one hour after the kinetic begins, 3 times higher
between the hour 1 and the hour 6 and 2 times bigger
between hour 6 and 7.
Conclusions
Micronization decrease the particle size of commercial
coQ10, producing microparticles diameters in a range
from 0.84 to 21.71 µm, with particle size distribution
narrower than commercial particles, modifying at the
same time the morphology, going from amorphous
accumulations to spheres.
The studied variables showed an effect on the
particle size. Temperature has a significant effect
at 1.0 and 2.5% w/w of coQ10 in a supercritical
solution. An increase of temperature induces bigger
particle sizes and a more important distribution of
sizes. The effect of the nozzle diameter is related
to temperature. With a concentration of coQ10 in
the supercritical solution of 2.5% w/w and 35°C, an
increase of the nozzle diameter induces bigger particle
diameters, opposing to 55°C where the contrary effect
is observed. Concerning concentration of coQ10 in
the supercritical solution, its increase induces more
important particle sizes and size distributions, and
morphological modification. This effect is more
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significant at higher temperatures.
A reduction of particle size possibly induces
an increase on contact surface, obtaining thus a
significant augmentation of the antioxidant capability
of the coenzyme; micronized coQ10 can achieve
a 4 times higher antioxidant capability than the
commercial one. Finally, the decrease of the particle
size of coQ10 considerably increases its solubilization
speed in ethanol, although it has been proved in
organic solvents, this possibly an indicator of the
bioavailability increase.
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